PMS-FLUTICASONE HFA
PMS-FLUTICASONE HFA
Approved
DIN Number
02503115
Drug Class
Human
Market Date
Aug 31, 2022
Company
HC
Pharmascience Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02503115
AIG Number0124685001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA05 FLUTICASONE
Product Specifications
Dosage FormMetered-Dose Aerosol
Route of AdministrationInhalation
,
Oral
AHFS Classification68:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FLUTICASONE PROPIONATEActive
Strength: 50 MCG / ACT
Monograph: FLUTICASONE PROPIONATE